Hercules Capital Management
Management criteria checks 2/4
Hercules Capital's CEO is Scott Bluestein, appointed in Apr 2014, has a tenure of 10.08 years. total yearly compensation is $8.89M, comprised of 7.3% salary and 92.7% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth $43.65M. The average tenure of the management team and the board of directors is 5.3 years and 3.8 years respectively.
Key information
Scott Bluestein
Chief executive officer
US$8.9m
Total compensation
| CEO salary percentage | 7.3% |
| CEO tenure | 10.1yrs |
| CEO ownership | 1.4% |
| Management average tenure | 5.3yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Hercules Capital: Winning Option In The Financial Services Space
Apr 24There Is A Reason Hercules Capital, Inc.'s (NYSE:HTGC) Price Is Undemanding
Apr 22
Hercules Capital: Record Year In 2023, 10% Yield
Mar 29Unlocking Hercules Capital's Income Potential: A Fresh Look At Dividend Timing Strategies
Feb 23Results: Hercules Capital, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 18Hercules Capital: Still Resilient With Solid Prospects Despite The VC Focus
Feb 17Hercules Capital: A Different Type Of VC-Focused BDC
Jan 16Hercules Capital Poised For Potential Market Surge In 2024
Dec 24Lacklustre Performance Is Driving Hercules Capital, Inc.'s (NYSE:HTGC) Low P/E
Dec 1810%-Yielding Hercules Capital: Better Ingredients, Better Outcomes
Dec 15Main Street Capital Vs. Hercules Capital: Why Choose?
Nov 22Hercules Capital: 10% Yield, My Largest BDC Position
Nov 1310%-Yielding Hercules Capital Is A BDC Superstar
Oct 10Hercules Capital: Venture Capital Financier Offering High Yield And Robust Balance Sheet
Sep 17Hercules Capital: 10% Yield, Strong Coverage, Low Leverage
Sep 09Let's Build A Bond Portfolio Together: Hercules Capital Bonds 2026 7.10%
Aug 15Hercules Capital: Fatter Yield, Surging Stock Price
Aug 05Hercules Capital: The Tide Is Turning - Buy While It's Cheap (Rating Upgrade)
Jun 28Hercules Capital raises dividend by 8.3% to $0.39/share, supplemental cash distribution of $0.08
Feb 14Hercules Capital: 2 Top Reasons To Buy This 10.1%-Yielding BDC
Jan 25Should You Buy Hercules Capital Before Or After Its Ex-Dividend Date?
Jan 11Hercules Capital: Bear Market Rally Fizzling Out
Dec 08Oak Street Health secures $300M in financing
Nov 16Hercules Capital: Double Your Cash Flow With This 10%+ Dividend
Nov 07Hercules Capital raises dividend by 2.9% to $0.36, supplemental cash distribution of $0.15
Oct 18Hercules Capital: Grab Its 13% Yield As Weak Holders Capitulate
Oct 03Hercules Capital: 10% Yield, Wake Up And Smell The Cash Flow
Aug 31Hercules Capital: 7% From An Investment Grade Bond With 4 Years To Maturity
Aug 23atai Life Sciences nabs $175M in loan facility from Hercules Capital
Aug 15Hercules Capital raises dividend by 6% to $0.35 , supplemental cash distribution of $0.15
Jul 26Hercules Capital: 14% Yield, Benefits From Rising Rates, Good Upside Potential
Jul 03Buy The Dip And Position For Higher Rates With Hercules Capital
Jun 02Hercules Capital: Buy This Fat 9.7% Yield While It's On Sale
May 24Hercules Capital: An Interesting BDC With A 7.2% 'Regular' Yield
Apr 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$9m | US$650k | US$334m |
| Sep 30 2023 | n/a | n/a | US$277m |
| Jun 30 2023 | n/a | n/a | US$302m |
| Mar 31 2023 | n/a | n/a | US$197m |
| Dec 31 2022 | US$7m | US$650k | US$100m |
| Sep 30 2022 | n/a | n/a | US$42m |
| Jun 30 2022 | n/a | n/a | US$12m |
| Mar 31 2022 | n/a | n/a | US$105m |
| Dec 31 2021 | US$6m | US$650k | US$172m |
| Sep 30 2021 | n/a | n/a | US$319m |
| Jun 30 2021 | n/a | n/a | US$339m |
| Mar 31 2021 | n/a | n/a | US$318m |
| Dec 31 2020 | US$7m | US$650k | US$226m |
| Sep 30 2020 | n/a | n/a | US$120m |
| Jun 30 2020 | n/a | n/a | US$96m |
| Mar 31 2020 | n/a | n/a | US$83m |
| Dec 31 2019 | US$8m | US$594k | US$173m |
| Sep 30 2019 | n/a | n/a | US$111m |
| Jun 30 2019 | n/a | n/a | US$128m |
| Mar 31 2019 | n/a | n/a | US$132m |
| Dec 31 2018 | US$11m | US$515k | US$76m |
| Sep 30 2018 | n/a | n/a | US$111m |
| Jun 30 2018 | n/a | n/a | US$109m |
| Mar 31 2018 | n/a | n/a | US$90m |
| Dec 31 2017 | US$3m | US$500k | US$78m |
Compensation vs Market: Scott's total compensation ($USD8.89M) is above average for companies of similar size in the US market ($USD6.67M).
Compensation vs Earnings: Scott's compensation has increased by more than 20% in the past year.
CEO
Scott Bluestein (45 yo)
10.1yrs
Tenure
US$8,891,994
Compensation
Mr. Scott Bluestein serves as Chief Executive Officer, President and Director at Hercules Capital, Inc. since July 18, 2019. He is responsible for the Hercules lending policies and risk management practice...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Investment Officer | 10.1yrs | US$8.89m | 1.42% $ 43.7m | |
| CFO & Chief Accounting Officer | 5.2yrs | US$3.04m | 0.22% $ 6.7m | |
| Chief Operating Officer | 8.3yrs | US$1.21m | 0.060% $ 1.8m | |
| Corporate Secretary | 2.3yrs | US$1.08m | 0.031% $ 937.5k | |
| Senior MD & Group Head of Technology | 5.3yrs | no data | no data | |
| Managing Director of Investor Relations & Corporate Communications | no data | no data | no data | |
| VP of Human Resources | no data | no data | no data | |
| Managing Director | 20.1yrs | no data | no data | |
| Senior MD & Group Head of Life Sciences | 5yrs | no data | no data | |
| Managing Director of Portfolio Management | 5.3yrs | no data | no data | |
| Managing Director | 14.1yrs | no data | no data | |
| Managing Director | 5.3yrs | no data | no data |
5.3yrs
Average Tenure
51yo
Average Age
Experienced Management: HTGC's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Investment Officer | 4.8yrs | US$8.89m | 1.42% $ 43.7m | |
| Independent Director | 5.3yrs | US$215.00k | 0.030% $ 933.3k | |
| Chairman of the Board & Lead Independent Director | 18.2yrs | US$310.00k | 0.070% $ 2.1m | |
| Independent Director | 2.5yrs | US$250.00k | 0.0078% $ 240.6k | |
| Independent Director | less than a year | US$39.99k | 0.00060% $ 18.4k | |
| Independent Director | 9.8yrs | US$205.00k | 0.056% $ 1.7m | |
| Independent Director | 2.8yrs | US$215.00k | 0.013% $ 388.0k | |
| Independent Board Directors | 1.9yrs | US$145.00k | 0.0050% $ 152.9k |
3.8yrs
Average Tenure
61.5yo
Average Age
Experienced Board: HTGC's board of directors are considered experienced (3.8 years average tenure).